Ke Ze Yong Xin
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ke Ze Yong Xin - overview
Established
2023
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Based in Shanghai, China, and founded in 2023, Shanghai Kezx Biotechnology Co. , Ltd. , trading under the name Ke Ze Yong Xin, provides RNA core backbone raw materials and delivery systems for the biotechnology industry. The company was founded by Dr.
Kun Zhang and a team of PhDs and post-docs from ETH Zurich. In April 2026, the firm closed a pre-series A funding round from Disheng Capital and Caleb Investment. The company works with pharmaceutical and biotech enterprises to provide mini-nucleic acid raw materials, nucleoside monomers, phosphoramidites, and delivery systems such as LNP and GalNAc. It also offers CRO and CDMO custom synthesis services for fluorine, amino acids, polypeptides, boric acids, and heterocyclic compounds.
The company generates revenue from B2B contracts by selling biochemical products and providing CRO and CDMO custom synthesis services. The company plans to use the latest funding to construct a production base for its wholly-owned subsidiary, Anhui Kezx Biotechnology Co. , Ltd. , and to accelerate capacity expansion.
Current Investors
Sealand Innovation, Caleb Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Medicinal Chemicals & Botanicals, Molecular Chemicals
Website
www.kezxbio.com/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.